LISDEXAMFETAMINE 20 MG CAPSULE

Lisdexamfetamine dimesylate
$2.5589per EA
DEA Schedule CII

Strength

20 mg/1

NDC

00480356601

Classification

Generic

Dosage Form

CAPSULE

Route

ORAL

Last Updated

4/22/2026

Active Ingredients

LISDEXAMFETAMINE DIMESYLATE

Approval Type

Generic (ANDA)

FDA Application

ANDA202802

On Market Since

12/17/2024

Pharmacological Classes

Central Nervous System Stimulant
Central Nervous System Stimulation

Price History

1W

0.0%

1M

-3.3%

3M

-19.4%

6M

-25.3%

1Y

-38.1%

3Y

N/A

5Y

N/A

All

-43.2%